New oral anticoagulants and their reversal agents

Atrial fibrillation is a commonly encountered pathology in medical practice, and its prevalence has shown a continuous rise over the past years. Atrial fibrillation has a significant impact on patients' quality of life, not only due to the standard anticoagulant treatment with vitamin K antagon...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Crista L. Laslo, Anca Pantea Stoian, Bogdan Socea, Dan N. Păduraru, Oana Bodean, Laura I. Socea, Tiberiu Paul Neagu, Ana Maria Alexandra Stănescu, Dragoș Marcu, Camelia C. Diaconu
Formato: Artigo
Idioma:Inglês
Publicado em: Ion Motofei, Carol Davila University 2018-10-01
Colecção:Journal of Mind and Medical Sciences
Assuntos:
atrial fibrillation
new oral anticoagulants
idarucizumab
andexanet-alpha
Acesso em linha:https://scholar.valpo.edu/cgi/viewcontent.cgi?article=1130&context=jmms
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados